Ginestier Christophe, Birnbaum Daniel, Charafe-Jauffret Emmanuelle
Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology "Equipe labellisée Ligue Contre le Cancer," Marseille, France.
Mol Cell Oncol. 2017 Apr 28;4(4):e1319896. doi: 10.1080/23723556.2017.1319896. eCollection 2017.
Tumors are organized in a cellular hierarchy with a population of cancer stem cell (CSC) driving cancer progression and resistance to treatment. Recently, we identified miR-600 as a bimodal switcher that balances breast CSC-fate from a self-renewing to a differentiation state, with a direct impact on tumor progression.
肿瘤是按照细胞层次结构组织起来的,其中一群癌症干细胞(CSC)推动着癌症的进展和对治疗的抗性。最近,我们将miR-600鉴定为一种双峰切换因子,它能平衡乳腺CSC的命运,使其从自我更新状态转变为分化状态,这对肿瘤进展有直接影响。